A randomized, double-blind, placebo-controlled phase II study of olanzapine based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B)
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Sakai H.ORCID,
Tsurutani J.ORCID,
Ozaki Y.,
Ishiguro H.,
Nozawa K.ORCID,
Yamanaka T.,
Aogi K.,
Matsumoto K.ORCID,
Iwasa T.,
Tokiwa M.ORCID,
Tsuneizumi M.,
Miyoshi Y.,
Kitazawa C.,
Yamamoto M.,
Takano Y.,
Imamura C.K.ORCID,
Chiba Y.,
Takiguchi D.,
Ezumi T.,
Takano T.ORCID
Funder
Daiichi Sankyo Europe
Daiichi Sankyo Co Ltd